Atropine Sulfate Injection
Product Images NDC 16729-484

This is a description of a medicine syringe containing Atropine Sulfate Injection, USP manufactured by Accord Healthcare, Inc. The syringe contains 0.05 mg of atropine sulfate and 9 mg of sodium chloride. The medicine is recommended to be used intravenously and should be stored between 20°C to 25°C (B8°F to 77°F). Aseptic technique should be used while using the syringe. The package also contains a caution to handle the syringe with care, and inspect it for damage before use.*

This is a set of instructions and information for using Atropine Sulfate Injection, USP. The syringe should be inspected for damage before use and handled with care since it contains liquid. Aseptic Technique should be used for assembly. The prescribed dosage should be followed as mentioned in the prescribing information. The syringe should be discarded after use, and any unused portion should be discarded as well. Each mL of the injection contains 0.1 mg of atropine sulfate monohydrate, equivalent to 0.083 mg of atropine, and 9 mg of sodium chloride. The pH of the injection falls in the range of 3.0 to 4.0. The medication and fluid path are sterile and non-pyrogenic. The manufacturer is Accord Healthcare, Inc., and the product is distributed by Intas Pharmaceuticals Limited.*

This is a description of a syringe containing Atropine Sulfate Injection, USP. The recommended dosage should be obtained from the prescribing information. The syringe should be handled with caution due to the liquid in glass construction. The syringe should be inspected for damage prior to assembly and the users should use aseptic technique. The syringe should be stored at a temperature between 20°C and 25°C. The product is sold by Accord Healthare, Inc. and the manufacturer is Intas Pharmaceuticals Limited in Ahmedabad-382 210, INDIA. The medication and fluid path are sterile and only pyrogenic if the cap is in place and the package is intact.*